Legal Marijuana Market Size, Share, and Trends 2026 to 2035

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis

Chapter 5. Market Dynamics Analysis and Trends

5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition

Chapter 6. Competitive Landscape

6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers

Chapter 7. Global Legal Marijuana Market, By Product

7.1. Legal Marijuana Market, by Product Type,
7.1.1. Oils
7.1.1.1. Market Revenue and Forecast
7.1.2. Buds
7.1.2.1. Market Revenue and Forecast
7.1.3. Tinctures
7.1.3.1. Market Revenue and Forecast

Chapter 8. Global Legal Marijuana Market, By Application

8.1. Legal Marijuana Market, by Application,
8.1.1. Mental Disorders
8.1.1.1. Market Revenue and Forecast
8.1.2. Chronic Pain
8.1.2.1. Market Revenue and Forecast
8.1.3. Cancer
8.1.3.1. Market Revenue and Forecast
8.1.4. Others
8.1.4.1. Market Revenue and Forecast

Chapter 9. Global Legal Marijuana Market, By Marijuana

9.1. Legal Marijuana Market, by Marijuana,
9.1.1. Medical
9.1.1.1. Market Revenue and Forecast
9.1.2. Adult Use
9.1.2.1. Market Revenue and Forecast

Chapter 10. Global Legal Marijuana Market, Regional Estimates and Trend Forecast

10.1. North America
10.1.1. Market Revenue and Forecast, by Product
10.1.2. Market Revenue and Forecast, by Application
10.1.3. Market Revenue and Forecast, by Marijuana
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, by Product
10.1.4.2. Market Revenue and Forecast, by Application
10.1.4.3. Market Revenue and Forecast, by Marijuana
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, by Product
10.1.5.2. Market Revenue and Forecast, by Application
10.1.5.3. Market Revenue and Forecast, by Marijuana
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product
10.2.2. Market Revenue and Forecast, by Application
10.2.3. Market Revenue and Forecast, by Marijuana
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, by Product
10.2.4.2. Market Revenue and Forecast, by Application
10.2.4.3. Market Revenue and Forecast, by Marijuana
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, by Product
10.2.5.2. Market Revenue and Forecast, by Application
10.2.5.3. Market Revenue and Forecast, by Marijuana
10.2.6. France
10.2.6.1. Market Revenue and Forecast, by Product
10.2.6.2. Market Revenue and Forecast, by Application
10.2.6.3. Market Revenue and Forecast, by Marijuana
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, by Product
10.2.7.2. Market Revenue and Forecast, by Application
10.2.7.3. Market Revenue and Forecast, by Marijuana
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product
10.3.2. Market Revenue and Forecast, by Application
10.3.3. Market Revenue and Forecast, by Marijuana
10.3.4. India
10.3.4.1. Market Revenue and Forecast, by Product
10.3.4.2. Market Revenue and Forecast, by Application
10.3.4.3. Market Revenue and Forecast, by Marijuana
10.3.5. China
10.3.5.1. Market Revenue and Forecast, by Product
10.3.5.2. Market Revenue and Forecast, by Application
10.3.5.3. Market Revenue and Forecast, by Marijuana
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, by Product
10.3.6.2. Market Revenue and Forecast, by Application
10.3.6.3. Market Revenue and Forecast, by Marijuana
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, by Product
10.3.7.2. Market Revenue and Forecast, by Application
10.3.7.3. Market Revenue and Forecast, by Marijuana
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product
10.4.2. Market Revenue and Forecast, by Application
10.4.3. Market Revenue and Forecast, by Marijuana
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, by Product
10.4.4.2. Market Revenue and Forecast, by Application
10.4.4.3. Market Revenue and Forecast, by Marijuana
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, by Product
10.4.5.2. Market Revenue and Forecast, by Application
10.4.5.3. Market Revenue and Forecast, by Marijuana
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, by Product
10.4.6.2. Market Revenue and Forecast, by Application
10.4.6.3. Market Revenue and Forecast, by Marijuana
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, by Product
10.4.7.2. Market Revenue and Forecast, by Application
10.4.7.3. Market Revenue and Forecast, by Marijuana
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product
10.5.2. Market Revenue and Forecast, by Application
10.5.3. Market Revenue and Forecast, by Marijuana
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, by Product
10.5.4.2. Market Revenue and Forecast, by Application
10.5.4.3. Market Revenue and Forecast, by Marijuana
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, by Product
10.5.5.2. Market Revenue and Forecast, by Application
10.5.5.3. Market Revenue and Forecast, by Marijuana

Chapter 11. Company Profiles

11.1. Aurora Cannabis
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. GW Pharmaceuticals, plc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Organigram Holding, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Canopy Growth Corporation
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Maricann Group, Inc.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Aphria, Inc.
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. Maricann Group, Inc.
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. The Cronos Group
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Tilray
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. ABcannMedicinals, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Lexaria Corp.
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms